BGF
BGF is a UK and Ireland growth capital investor that has deployed over £4.7 billion across 600+ portfolio companies since founding, serving high-growth scaling businesses with expansion capital and strategic support.
- Company typePrivate
- Founded1994
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What BGF does
BGF is a UK and Ireland growth capital investor that deploys minority and majority equity into high-growth, scaling businesses. Since founding it has invested over £4.7 billion across more than 600 portfolio companies, making it the most active growth capital provider in the region. Its portfolio spans medical devices (OrganOx), diagnostics (Cyted Health), retail software (Citrus-Lime), beauty tech (The Beauty Tech Group), AI consulting (Optima Partners), infrared sensors (Phlux Technology), website accessibility (Recite Me), housebuilding (Cruden), and digital services (Granite Digital), reflecting a deliberately sector-agnostic, horizontal approach focused on businesses with credible expansion trajectories.
BGF's revenue model is investment-driven rather than product-based: it realises returns through capital appreciation on equity stakes, demonstrated by exits such as the $1.5bn sale of OrganOx to Terumo Corporation, the £55.6m sale of Monodraught to Genuit Group, a 4x return on Optima Partners, and the £300m+ market-cap IPO of The Beauty Tech Group on the London Stock Exchange in October 2025. Ticket sizes range from single-digit millions (e.g., £9m led round into Phlux Technology) to mid-teens millions (£15m into Cruden), with selective participation in larger rounds (£44m Series B into Cyted Health). The firm is currently exploring its first external institutional fundraise, targeting £500 million with Lazard as advisor, alongside a five-year £3bn UK support plan that includes £300m for female-powered businesses and £400m for the North West.
Operationally, BGF sources deals through an extensive UK and Ireland network and supports portfolio companies with strategic guidance, leadership changes, and international expansion assistance. Its leadership includes Chris Olds (Chief Operating Officer) and Rosaleen Blair (Non-Executive Director), with Anita Dougall (CEO of Sagacity Solutions) recently appointed as Non-Executive Director to deepen data-driven innovation expertise on the board. (Note: conflicting firmographics describe BGF as a Berlin-based workplace health management firm; the detailed source material overwhelmingly supports the UK/Ireland growth capital investor profile.)
BGF firmographics
Firmographics- Name
- BGF
- Legal name
- BGF
- Website
- https://bgf-berlin.de
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BGF is a UK and Ireland growth capital investor that has deployed over £4.7 billion across 600+ portfolio companies since founding, serving high-growth scaling businesses with expansion capital and strategic support.
- Ownership category
- akta.pro rank
BGF industry classification
Industry- Product category
- Growth Capital Investment
- NAICS
- Portfolio Management and Investment Advice (52394), All Other Financial Investment Activities (52399)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
- akta.pro secondary industry
- Technology & Software Growth Equity (FSANACAA)
Keywords
Where BGF is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Markets served
BGF business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others
BGF product offering
Product offeringCore offering
BGF is a growth capital investor that deploys long-term equity capital into high-growth businesses across the UK and Ireland. The firm invests in scaleup and early-stage companies across multiple sectors, with typical investments ranging from multi-million pound cheques to £15m+ rounds, and provides strategic support alongside capital. BGF has invested over £4.7 billion across 600+ businesses since founding, with recent notable exits including OrganOx (sold for $1.5bn) and Monodraught (sold for £55.6m).
Differentiator
Problem solved
Functional benefit
Products and services
- Growth Capital Investment
Quantifiable outcome
- Over £4.7 billion invested across 600+ UK and Ireland businesses since founding
- +1 more outcomes
Companies that use BGF
Customer profileSegments1 record
Ideal customer profiles1 record
BGF technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BGF partnerships and signals
Strategic signalScale indicators8 records
Recent moves7 records
Expansion highlights5 records
BGF competitors and assessment
Company assessmentDirect peers
- LDC (Lloyds Development Capital): LDC is Lloyds Banking Group's private equity arm, investing growth and development capital in UK SMEs. Like BGF, it is bank-backed and targets UK mid-market growth equity, making it the closest structural peer to BGF.
- Inflexion Private Equity: Inflexion invests growth and buyout capital in UK and Northern European mid-market companies. It overlaps directly with BGF on UK growth equity cheque sizes, sectors, and stage focus.
- Livingbridge: Livingbridge (formerly ISIS Equity Partners) is a UK mid-market growth and buyout investor, with a portfolio spanning tech, consumer, and services. It is a long-standing direct competitor to BGF in UK growth capital.
- Phoenix Equity Partners: Phoenix Equity Partners is a UK mid-market growth and buyout firm focused on lower mid-market companies. It targets similar cheque sizes and sectors to BGF's growth capital strategy.
- Lyceum Capital: Lyceum Capital is a UK growth investor focused on consumer-facing and tech-enabled businesses. It directly competes with BGF for UK growth equity opportunities in similar ticket sizes.
- August Equity: August Equity is a UK lower mid-market growth and buyout investor. It is comparable to BGF on UK focus, cheque size, and stage profile.
- Mobeus Equity Partners: Mobeus is a UK growth and small-cap investor backing UK SMEs in similar sectors and cheque sizes. It directly competes with BGF for UK lower mid-market growth deals.
- YFM Equity Partners: YFM is one of the UK's most active smaller mid-market PE investors, with regional funds and growth capital focus. It overlaps with BGF on UK growth equity in smaller cheque sizes.
- NVM Private Equity: NVM is a long-established UK growth capital investor backing profitable SMEs. NVM is explicitly cited as a co-investor with BGF in Beauty Tech Group, confirming direct peer overlap in UK growth capital.
- Foresight Group: Foresight Group invests growth and venture capital across UK regions with sector focuses including deeptech and life sciences. Foresight co-invested with BGF in Phlux Technology, confirming direct peer overlap on UK growth deals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
BGF financial estimates
Financial estimateRevenue estimate
Valuation estimate
BGF leadership team
Management profileNumber of profiles
Profiles3 records
BGF funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BGF M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BGF
What does BGF do?
BGF is a growth capital investor that deploys long-term equity capital into high-growth businesses across the UK and Ireland. The firm invests in scaleup and early-stage companies across multiple sectors, with typical investments ranging from multi-million pound cheques to £15m+ rounds, and provides strategic support alongside capital. BGF has invested over £4.7 billion across 600+ businesses since founding, with recent notable exits including OrganOx (sold for $1.5bn) and Monodraught (sold for £55.6m).
Is BGF a public or private company?
BGF is a private company. It is classified as unknown and is currently operating.
When was BGF founded?
BGF was founded in 1994. It employs 1 to 10 people.
Where is BGF based?
BGF is headquartered in Berlin, Germany, in the Europe region.
Who are BGF's main competitors?
Direct peers on record are LDC (Lloyds Development Capital), Inflexion Private Equity, Livingbridge, Phoenix Equity Partners, Lyceum Capital, August Equity, Mobeus Equity Partners, YFM Equity Partners, NVM Private Equity and Foresight Group.
Does BGF have an API?
No public API is recorded for BGF.
What industry is BGF in?
BGF's product category is Growth Capital Investment. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.